You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 280 No. 21, December 2, 1998 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contribution
 This Article
 •Abstract
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (406)
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Obesity
 •Cardiovascular System
 •Cardiovascular Disease/ Myocardial Infarction
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Abdominal Adiposity and Coronary Heart Disease in Women

Kathryn M. Rexrode, MD; Vincent J. Carey, PhD; Charles H. Hennekens, MD; Ellen E. Walters, MS; Graham A. Colditz, MD; Meir J. Stampfer, MD; Walter C. Willett, MD; JoAnn E. Manson, MD

JAMA. 1998;280:1843-1848.

ABSTRACT

Context.— Obesity is a well-established risk factor for coronary heart disease (CHD), but whether regional fat distribution contributes independently to risk remains unclear.

Objective.— To compare waist-hip ratio (WHR) and waist circumference in determining risk of CHD in women.

Design and Setting.— Prospective cohort study among US female registered nurses participating in the Nurses' Health Study conducted between 1986, when the nurses completed a questionnaire, and follow-up in June 1994.

Participants.— A total of 44,702 women aged 40 to 65 years who provided waist and hip circumferences and were free of prior CHD, stroke, or cancer in 1986.

Main Outcome Measures.— Incidence of CHD (nonfatal myocardial infarction or CHD death).

Results.— During 8 years of follow-up 320 CHD events (251 myocardial infarctions and 69 CHD deaths) were documented. Higher WHR and greater waist circumference were independently associated with a significantly increased age-adjusted risk of CHD. After adjusting for body mass index (BMI) (defined as weight in kilograms divided by the square of height in meters) and other cardiac risk factors, women with a WHR of 0.88 or higher had a relative risk (RR) of 3.25 (95% confidence interval [CI], 1.78-5.95) for CHD compared with women with a WHR of less than 0.72. A waist circumference of 96.5 cm (38 in) or more was associated with an RR of 3.06 (95% CI, 1.54-6.10). The WHR and waist circumference were independently strongly associated with increased risk of CHD also among women with a BMI of 25 kg/m2 or less. After adjustment for reported hypertension, diabetes, and high cholesterol level, a WHR of 0.76 or higher or waist circumference of 76.2 cm (30 in) or more was associated with more than a 2-fold higher risk of CHD.

Conclusions.— The WHR and waist circumference are independently associated with risk of CHD in women.



INTRODUCTION
 Jump to Section
 •Top
 •Introduction
 •Methods
 •Results
 •Comment
 •Author information
 •References

OBESITY is well recognized as a major risk factor for coronary heart disease (CHD) in men and women.1-3 However, since Vague's4 description of the association between upper body obesity and cardiovascular disease, the relative importance of total and regional obesity has been debated. Abdominal adiposity has been linked to significant metabolic abnormalities, including insulin resistance, hyperinsulinemia, and elevated triglyceride levels, as well as increased incidence of hypertension,5 glucose intolerance,6 and diabetes mellitus.7 Several studies suggest that abdominal adiposity, as measured by waist-hip ratio (WHR), is an independent risk factor for CHD in men8-9 and perhaps also in women.10-11 Waist circumference has also been associated with increased risk of CHD9, 12 and has been advocated by some as a simpler measure of abdominal obesity.13 However, whether regional obesity remains a risk factor after taking total adiposity into account remains controversial. The purpose of this study was to determine the risk of CHD associated with abdominal adiposity in women and to compare the effects of WHR and waist circumference.


METHODS
 Jump to Section
 •Top
 •Introduction
 •Methods
 •Results
 •Comment
 •Author information
 •References

The Nurses' Health Study (NHS) cohort was formed in 1976 when 121,701 female registered nurses, aged 30 to 55 years and living in 11 US states, returned a mailed questionnaire. These women have answered questionnaires every 2 years, reporting information about exposures, risk factors, and health outcomes, including the diagnosis of myocardial infarction (MI).

All covariates for these analyses were obtained from the 1986 questionnaire with the exception of height (collected in 1976), aspirin intake (collected in 1984), family history of MI (collected in 1976 and 1980), and oral contraceptive use (collected biennially from 1976 to 1984). In 1986, women were instructed to measure their waist at the level of the umbilicus and their hips at the largest circumference with a tape measure while standing relaxed and to report values to the nearest quarter inch (reported herein in centimeters [inches]).

Documentation of CHD

The primary end point for this analysis was CHD, defined as incidence of nonfatal MI or fatal CHD. Myocardial infarction was classified by medical record review using the World Health Organization criteria of symptoms and either diagnostic electrocardiographic changes or elevated cardiac enzyme levels.14 Silent MI was excluded. Fatal CHD was considered confirmed if hospital or autopsy records confirmed fatal MI or the death certificate listed CHD as the primary cause of death and available evidence from next of kin, hospital records, or prior participant report indicated a previous diagnosis of CHD. If the cause of death on the death certificate could not be confirmed by supplemental confirmatory data, the death was not included as an end point. Deaths of nonrespondents to the biennial questionnaire were ascertained by surveillance of the National Death Index and vital records of the states. There were 251 nonfatal MIs and 69 confirmed CHD deaths.

Validation Studies

In 1987, we assessed the validity of self-reported waist and hip measures in a random sample of 140 participants in the greater Boston, Mass, area. The average of 2 technician measurements spaced 6 months apart was compared with the waist and hip circumference values reported on the most recent questionnaire. Women reliably reported waist circumference, but underestimated hip circumference by an average of 1.4 cm (0.54 in). Thus, reported WHR was slightly higher than that obtained from directly measured values. Crude Pearson correlation coefficients for reported and measured circumferences for waist and hip and the WHR were 0.89, 0.84, and 0.70, respectively. After adjusting for age and body mass index (BMI) and correcting for random within-person variability, the correlations were 0.64, 0.60, and 0.62, respectively.15

The BMI was calculated by dividing weight (in kilograms) in 1986 by the square of height (in meters) reported in 1976. In women, BMI is strongly correlated with absolute fat mass as determined by hydrostatic underwater weighing (r=0.84-0.92)16 and is minimally correlated with height (r= -0.06 in this cohort). Heavier women were somewhat less likely to report waist and hip measurements.

In a separate validation study of weight in a subsample of 184 study participants, the Spearman correlation between self-reported and measured weight was 0.96, although self-report averaged 1.5 kg less than directly measured weight.17 This difference corresponds to an average difference in BMI of 0.5 kg/m2. Participants in the NHS are similar to the national average BMI (26.1 kg/m2 among white women in 1988-1991),18 with a mean BMI of 25.4 kg/m2 for the entire NHS cohort. Since heavier women were somewhat less likely to report circumference measurements, the average BMI for the population used in our analyses was 23.6 kg/m2 (in 1986).

Data Analysis

Of the 102,252 women who responded to the 1986 questionnaire, 89,921 were free of prior history of heart disease, stroke, or cancer. Of these, 98 failed to provide height in 1976, 18,013 did not report weight in 1986, and 27,012 failed to provide waist or hip circumference measurements. Of the remaining 44,798 women, outlier detection procedures19 identified 137 individuals who were determined to have implausible values of waist, hip, or BMI in 1986 (see below). This resulted in 44,702 individuals with relevant anthropometric measures and outcomes. Covariate information was incomplete for 3401 women who were therefore excluded from multivariate analyses. The most frequently missing (nonexclusive) covariates were lack of information about aspirin use (2046 women), dietary information (942 women), and physical activity (111 women). The women with missing covariate information appeared similar in all other regards to the other women who had complete data. Multivariate analyses that include all relevant covariates were performed on the 41,301 women with complete data.

A generalized extreme studentized deviate outlier detection procedure19 was used to identify outlying values of BMI, leading to exclusion of all BMI values higher than 48.9 kg/m2. Clinical judgment led to the exclusion of waist measures greater than 139.7 cm (55 in) or less than 38.1 cm (15 in) and hip measures greater than 165.1 cm (65 in) or less than 50.8 cm (20 in). Pearson correlations among the anthropometric variables were calculated. Person-years of follow-up were calculated as the time from completion of the 1986 questionnaire to June 1994 or the diagnosis of an end point, whichever came first. Incidence rates were calculated by dividing the number of new cases by the number of person-years of follow-up for each category. Rates were age-adjusted in 5-year age intervals. Cox proportional hazards models were used to estimate the relative risk of CHD outcomes across each anthropometric category. Models were fit controlling simultaneously for age and available relevant confounders.


RESULTS
 Jump to Section
 •Top
 •Introduction
 •Methods
 •Results
 •Comment
 •Author information
 •References

Table 1 shows the relationship of WHR and waist circumference to baseline characteristics in 1986. The prevalence of current smokers increased with higher WHR but declined with larger waist circumference. Waist circumference was weakly correlated with height (r=0.14) and strongly correlated with weight (r=0.82) and BMI (r=0.81), while WHR was not correlated with height (r= -0.01) and was more weakly associated with weight (r=0.31) and BMI (r=0.34).


View this table:
[in this window]
[in a new window]
Table 1.—Baseline Characteristics of Women in the Nurses' Health Study, According to Waist-Hip Ratio Category and Waist Circumference in 1986


During 342,441 person-years of follow-up we documented 320 CHD end points (251 nonfatal MIs and 69 CHD deaths). Age-adjusted risk of CHD was positively associated with WHR and waist circumference (Table 2). In categorical models adjusted for age alone, WHR showed a stronger gradient than waist circumference for risk of CHD. Women with a WHR of 0.88 or higher had a relative risk (RR) of 5.04 (95% confidence interval [CI], 2.92-8.71) for CHD compared with women with a WHR of less than 0.72. Waist circumference was also directly associated with risk, with an RR of 3.24 (95% CI, 2.10-5.01) for women with a waist circumference of 96.5 cm (38 in) compared with women with waist circumference of less than 71.1 cm (28 in).


View this table:
[in this window]
[in a new window]
Table 2.—Age-Adjusted and Multivariate Relative Risks (95% Confidence Intervals) for Coronary Heart Disease,* According to Waist-Hip Ratio and Waist Circumference


Measurements of both central and total obesity were independently associated with increased risk of CHD in stratified analyses. As shown in Figure 1, higher WHR was associated with increased age-adjusted risk of CHD, regardless of BMI tertile. Within any BMI tertile, women in the highest WHR tertile had a 2-fold higher incidence of CHD than those in the lowest WHR tertile. Within each WHR tertile, higher BMI also was generally associated with increased risk. As shown in Figure 2, within each tertile of BMI, larger waist circumference was also associated with increased risk of CHD.



View larger version (36K):
[in this window]
[in a new window]
Figure 1.—Age-adjusted incidence rates for coronary heart disease according to body mass index and waist-hip ratio tertiles. Numbers at the top of each bar indicate incidence.




View larger version (36K):
[in this window]
[in a new window]
Figure 2.—Age-adjusted incidence rates for coronary heart disease according to body mass index and waist circumference tertiles.


Multivariate models were fit to adjust simultaneously for regional and total adiposity measures as well as for other cardiac risk factors, including smoking, alcohol, physical activity, menopausal status, parental history of MI, hormone replacement therapy use, oral contraceptive use, saturated fat consumption, antioxidant vitamin score, and aspirin use (Table 2). After adjustment for BMI and other cardiac risk factors, women with a WHR of 0.88 or higher had an RR of 3.25 (95% CI, 1.78-5.95) compared with those with a WHR of less than 0.72. The BMI also remained significant in these models. As a continuous variable, each 0.02 of WHR was associated with an RR of 1.04 (95% CI, 1.02-1.06). Multivariate models were also performed including terms for both waist circumference and BMI. In multivariate models women with a waist circumference of 96.5 cm (38 in) or greater had an RR of 3.06 (95% CI, 1.54-6.10) compared with women with waist measurements of less than 71.1 cm (28 in). The BMI was not significant in these models. As a continuous variable, each additional 2.54 cm (1 in) of waist circumference was associated with an RR of 1.07 (95% CI, 1.03-1.12). Omitting BMI from the models modestly strengthened the association.

To compare directly WHR and waist circumference, we also performed multivariate models using quintiles of WHR and waist circumference for the cohort (Table 3). After adjustment for BMI and other cardiac risk factors, women in the highest WHR quintile had an RR of 2.58 (95% CI, 1.58, 4.22) for CHD compared with women in the lowest quintile. Women in the highest waist circumference quintile had an RR of 2.44 (95% CI, 1.34-4.44) for CHD compared with those in the lowest quintile. Hip circumference had a weak inverse but not significant association with CHD in models that included height and waist and hip circumferences as separate terms.


View this table:
[in this window]
[in a new window]
Table 3.—Multivariate Relative Risks (95% Confidence Intervals) for Coronary Heart Disease, According to Quintiles of Waist-Hip Ratio and Waist Circumference


We also examined whether the associations of WHR and waist circumference were modified by age, BMI, and use of hormone replacement therapy (Table 4). The WHR was more strongly associated with risk of CHD in women younger than 60 years than in those aged 60 years or older (for WHR >=0.88, RR, 4.47 [95% CI, 2.04-9.80] among the younger women, and RR, 1.86 [95% CI, 0.72-4.77] among the older women). Waist circumference was also a stronger predictor of CHD risk for younger than older women. There were no significant differences in the strength of association with CHD for premenopausal or postmenopausal women, after adjustment for age, with regard to WHR and waist circumference (data not presented).


View this table:
[in this window]
[in a new window]
Table 4.—Multivariate Relative Risks* (95% Confidence Intervals) for Coronary Heart Disease,{dagger} According to Waist-Hip Ratio Category, Stratified by Age, Body Mass Index, and Use of Hormone Replacement Therapy{ddagger}


When we stratified the sample according to current US Department of Agriculture desirable weight guidelines of BMI of less than 25 kg/m2 or of 25 kg/m2 or higher, WHR was strongly associated with increased risk of CHD in both groups (Table 4). Waist circumference was strongly associated with increased CHD risk among women with a BMI of less than 25 kg/m2 but was not significantly predictive for women with a BMI of 25 kg/m2or higher. However, few women with large waist circumferences had a BMI of less than 25 kg/m2. Because current hormone replacement therapy users had lower WHR and waist circumference values than past and never users, we examined the relationship between abdominal adiposity and CHD stratified by hormone replacement therapy use (Table 4). The association with CHD was significant for WHR and waist circumference only among women who had never used hormone replacement therapy, although the number of cases among past and current users was small. Formal interaction terms between hormone replacement therapy and measures of abdominal adiposity were nonsignificant.

To assess further the independent effects of waist circumference and WHR, we obtained a measure of waist circumference independent of BMI, by fitting a simple linear regression model for waist-hip ratio or waist circumference given BMI and entering the residuals into the model. The use of BMI-adjusted waist circumference residuals did not affect overall model fit, but the RR for each additional 2.54 cm (1 in) of waist was 1.28, compared with an RR of 1.07 in the linear model. For BMI-adjusted WHR residuals the RR for each 0.02 unit of WHR was 1.37, compared with an RR of 1.02 in the linear model that included both BMI and WHR. We also performed analyses correcting for measurement error. Correcting for the within-person variation noted in the validation study15 increased the RR for CHD from 1.02 to 1.12 (95% CI, 1.06-1.14) for each 0.02 increase in WHR. Correcting for measurement error increased the RR for each inch of waist from 1.07 (95% CI, 1.04-1.13) to 1.15 (95% CI, 1.06-1.25).

Because hypertension, high cholesterol level, and diabetes are direct effects of central and total adiposity, we deliberately did not control for these factors in primary analyses. However, to assess residual effects we added these biological mediators stepwise into multivariate models (Table 4). After adjustment for BMI and reported hypertension, diabetes, high cholesterol level, and other cardiac risk factors, women with a WHR of 0.88 or higher had an RR of 2.43 (95% CI, 1.32-4.48) for CHD compared with women with a WHR of less than 0.72 (Table 2). Waist circumference was also strongly associated with CHD, even after controlling for these biological mediators. Women with a waist circumference of 96.5 cm (38 in) or greater had an RR of 2.32 (95% CI, 1.16-4.63) for CHD, compared with those women with a waist circumference of less than 71.1 cm (28 in).


COMMENT
 Jump to Section
 •Top
 •Introduction
 •Methods
 •Results
 •Comment
 •Author information
 •References

We found that measures of regional fat distribution are independently associated with risk of CHD in women. In this cohort, both WHR and waist circumference were significantly associated with increased risk of CHD, even after controlling for BMI. In analyses stratified by BMI, higher WHR or waist circumference tertile was associated with higher risk of CHD, regardless of BMI tertile (Figure 1 and Figure 2). After controlling for BMI and other cardiac risk factors, women with a WHR of 0.76 or greater were more than twice as likely to develop CHD during follow-up, while women with a WHR higher than 0.88 were more than 3 times as likely to develop CHD. Women in the highest quintile of WHR or waist circumference were nearly 2.5 times more likely to develop CHD than women in the lowest quintile.

Subgroup analyses in men have suggested that WHR may be a better predictor of cardiovascular risk than BMI among men older than 65 years.9 Although our population was slightly younger, we found that WHR and waist circumference were more strongly associated with risk of CHD in women younger than 60 years than in those aged 60 years or older. The WHR was associated with increased risk of CHD, regardless of menopausal status and whether women were of "normal" weight or were overweight. In subgroup analyses, the relationship between abdominal adiposity appeared stronger in women who had never used hormone replacement therapy, although the numbers of cases were small among past and current users. Formal interaction terms were nonsignificant. Further studies of the potential interactions between weight, fat distribution, and hormone replacement therapy are necessary.

While direct effects of obesity, such as hypertension, diabetes mellitus, and high cholesterol level, appear to mediate the effects of obesity, more than a 2-fold residual risk of CHD was seen among women in the highest WHR category (>=0.88), even after controlling for these biological mediators. Since our measurement of these self-reported variables was imperfect, residual confounding by these factors is one explanation. However, other biological mechanisms, including lower high-density lipoprotein cholesterol level, higher serum triglyceride, insulin, and androgen levels, and increased insulin resistance, may also mediate the effects of abdominal adiposity.6, 20-21

This study has several strengths. Follow-up rates in this large prospective cohort are high, end points have been carefully documented, and reliability of self-reported risk factor information has been high.22 Among a random sample of women in this cohort, all of the self-reports of hypertension, 87.5% of reports of elevated cholesterol level,23 and 98.4% of reported cases of diabetes mellitus24 were confirmed by medical record review. Although all of our anthropometric measures are by self-report, the validity of self-reported weight, as well as waist and hip circumference measurements, is fairly high in this population of female health professionals.15 Correction for the error in these measurements15 strengthened the associations between WHR or waist circumference and CHD. The range of WHR and waist circumference in our population may be somewhat narrower than that of the general population, since heavier women were somewhat less likely to report waist and hip circumferences. However, WHR was associated with increased risk even among heavier women.

Our results are similar to those of the few previous studies that have examined regional fat distribution and risk of CHD in women. The WHR was a stronger predictor of CHD mortality than was BMI among women aged 55 to 69 years of age in the Iowa Women's Health Study.11 Women in the highest WHR tertile had a multivariate RR of 2.8 compared with those in the lowest tertile; WHR remained a significant predictor even after controlling for hypertension and diabetes. In a smaller population-based cohort in Sweden, women in the highest quintile of WHR had an age-adjusted RR of 8.2 for MI compared with those in the lowest WHR quintile.10 High WHR has also been associated with increased mortality in women.25 Several studies have observed increased risks associated with abdominal adiposity as measured by skinfold thickness ratios in women.26-28

In men, several studies support significant risk associated with abdominal adiposity. In the Health Professionals' Follow-up Study, men older than 65 years who were in the highest WHR quintile had a nearly 3-fold increased risk of CHD compared with those in the lowest quintile.9 In 2 other studies, the WHR was associated with increased risk of MI8 and cardiovascular mortality29 in men. Additionally, abdominal adiposity as assessed by skinfold measurements was a risk factor for CHD among men in several studies.12, 30-31

Although WHR and waist circumference are imperfect proxies for visceral adipose tissue accumulation, these measures are relatively easy to obtain and appear to impart clinically useful information regarding risk of CHD. Although WHR is somewhat more cumbersome to measure and calculate than waist circumference, in our study WHR appeared to be a slightly better measure than waist circumference of cardiac risk in multivariate models including BMI. The WHR is less strongly correlated with BMI and therefore may reflect more independent information about regional fat deposition. Waist circumference is simple to measure and has been advocated by some as a single measure to assess the need for weight loss, since it reflects both total adiposity and central fat deposition. A threshold of 80 cm (31.5 in) has been associated with a high sensitivity and specificity (>96.5%) for correctly identifying women with either a BMI higher than 25 kg/m2 or a WHR greater than 0.80.13 In our study, waist circumference greater than 76.2 cm (30 in) was associated with significantly increased risk of CHD.

Our data suggest that measures of abdominal adiposity are associated with risk of CHD in middle-aged women. In our cohort, both WHR and waist circumference were independently associated with risk of CHD, even after controlling for BMI. Prevention of obesity is the most effective means of reducing risk of abdominal adiposity, and interventions that effectively reduce total adiposity will also reduce WHR and waist circumference.32-33 In addition, WHR and waist circumference may be modified by behavioral factors, such as increased physical activity,34 smoking cessation, and changes in dietary intake. Because of the strong relationship of both central and total obesity with CHD, continued efforts at primary prevention of obesity and further research on modification of abdominal adiposity are necessary.


AUTHOR INFORMATION
 Jump to Section
 •Top
 •Introduction
 •Methods
 •Results
 •Comment
 •Author information
 •References

This study was supported by grants CA 40356 and HL 34595 from the National Institutes of Health, Bethesda, Md.

We are indebted to the participants in the Nurses' Health Study for their outstanding commitment and cooperation and to Mark Shneyder, Karen Corsano, Barbara Egan, Lisa Dunn, and Gary Chase for their expert and unfailing assistance.

Reprints: Kathryn M. Rexrode, MD, Division of Preventive Medicine, Brigham and Women's Hospital, 900 Commonwealth Ave E, Boston, MA 02215 (e-mail: kmrexrode{at}bics.bwh.harvard.edu).

From the Division of Preventive Medicine (Drs Rexrode, Hennekens, and Manson) and the Channing Laboratory (Drs Carey, Colditz, Willett, and Manson and Ms Walters), Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; Departments of Epidemiology (Drs Hennekens, Colditz, Stampfer, Willett, and Manson) and Nutrition (Drs Willett and Stampfer), School of Public Health; and Department of Ambulatory Care and Prevention (Dr Hennekens), Harvard Medical School, Boston, Mass.


REFERENCES
 Jump to Section
 •Top
 •Introduction
 •Methods
 •Results
 •Comment
 •Author information
 •References

1. Willett WC, Manson JE, Stampfer MJ, et al. Weight, weight change, and coronary heart disease in women. JAMA. 1995;273:461-465. FREE FULL TEXT
2. Curb JD, Marcus EB. Body fat, coronary heart disease, and stroke in Japanese men. Am J Clin Nutr. 1991;53:1612S-1615S.
3. Fraser GE, Strahan TM, Sabate J, Beeson WL, Kissinger D. Effects of traditional coronary risk factors on rates of incident coronary events in a low-risk population. Circulation. 1992;86:406-413. FREE FULL TEXT
4. Vague J. The degree of masculine differentiation of obesities. Am J Clin Nutr. 1956;4:20-34. ABSTRACT
5. Folsom A, Prineas R, Kaye S, Munger R. Incidence of hypertension and stroke in relation to body fat distribution and other risk factors in older women. Stroke. 1990;21:701-706. FREE FULL TEXT
6. Despres JP, Moorjani S, Lupien PJ, et al. Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Arteriosclerosis. 1990;10:497-511. FREE FULL TEXT
7. Carey V, Walters E, Colditz G, et al. Body fat distribution and risk of non-insulin-dependent diabetes in women. Am J Epidemiol. 1997;145:614-619. FREE FULL TEXT
8. Larsson B, Svardsudd K, Welin L, et al. Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death. Br Med J (Clin Res Ed). 1984;288:1401-1404. FREE FULL TEXT
9. Rimm EB, Stampfer MJ, Giovannucci E, et al. Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men. Am J Epidemiol. 1995;141:1117-1127. FREE FULL TEXT
10. Lapidus L, Bengtsson C, Larsson B, et al. Distribution of adipose tissue and risk of cardiovascular disease and death. Br Med J (Clin Res Ed). 1984;289:1257-1261. FREE FULL TEXT
11. Prineas R, Folsom A, Kaye SA. Central adiposity and increased risk of coronary artery disease mortality in older women. Ann Epidemiol. 1993;3:35-41. PUBMED
12. Higgins M, Kannel W, Garrison R, Pinsky J, Stokes J. Hazards of obesity: the Framingham experience. Acta Med Scand Suppl. 1988;723:23-36. PUBMED
13. Lean M, Han T, Morrison C. Waist circumference as a measure for indicating the need for weight management. BMJ. 1995;311:158-161. FREE FULL TEXT
14. Rose G, Blackburn H. Cardiovascular Survey Methods. Geneva, Switzerland: World Health Organization; 1982. WHO Monograph Series No. 56.
15. Rimm EB, Stampfer MJ, Colditz GA, et al. Validity of self-reported waist and hip circumferences in men and women. Epidemiology. 1990;1:466-473. PUBMED
16. Siegelman D, Israel RG, Bouchard C, Willett WC. Absolute fat mass, percent body fat, and body-fat distribution. Am J Clin Nutr. 1992;55:1033-1044. FREE FULL TEXT
17. Willett W, Stampfer M, Bain C, et al. Cigarette smoking, relative weight, and menopause. Am J Epidemiol. 1983;117:651-658. FREE FULL TEXT
18. Kuczmarski R, Flegal K, Campbell S, Johnson C. Increasing prevalence of overweight among US adults. JAMA. 1994;272:205-211. FREE FULL TEXT
19. Rosner BT. Percentage points for a generalized ESD many-outlier procedure. Technometrics. 1983;25:165-172.
20. Haffner SM, Katz MS, Dunn JF. Increased upper body and overall adiposity is associated with decreased sex hormone binding globulin in postmenopausal women. Int J Obes. 1991;15:471-478. ISI | PUBMED
21. Peiris AN, Struve MF, Kissebah AH. Relationship of body fat distribution to the metabolic clearance of insulin in premenopausal women. Int J Obes. 1987;11:581-589. ISI | PUBMED
22. Colditz GA, Stampfer MJ, Willett WC, et al. Reproducibility and validity of self-reported menopausal status in a prospective cohort study. Am J Epidemiol. 1987;126:319-325. FREE FULL TEXT
23. Colditz G, Martin P, Stampfer M, et al. Validation of questionnaire information on risk factors and disease outcomes in a prospective study of women. Am J Epidemiol. 1986;123:894-900. FREE FULL TEXT
24. Manson J, Colditz G, Stampfer M, et al. A prospective study of maturity-onset diabtetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med. 1991;151:1141-1147. FREE FULL TEXT
25. Folsom AR, Kaye SA, Sellers TA, et al. Body fat distribution and 5-year risk of death in older women. JAMA. 1993;269:483-587. FREE FULL TEXT
26. Duncan B, Chambless L, Schmidt M, et al. Correlates of body fat distribution. Ann Epidemiol. 1995;5:192-200. FULL TEXT | PUBMED
27. Kannel WB, Cupples LA, Ramaswami R, et al. Regional obesity and risk of cardiovascular disease. J Clin Epidemiol. 1991;44:183-190. FULL TEXT | ISI | PUBMED
28. Freedman D, Williamson D, Croft J, Ballew C, Byers T. Relation of body fat distribution to ischemic heart disease. Am J Epidemiol. 1995;142:53-63. FREE FULL TEXT
29. Terry R, Page W, Haskell W. Waist/hip ratio, body mass index and premature cardiovascular disease mortality in US Army veterans during a twenty-three year follow-up study. Int J Obes Relat Metab Disord. 1992;16:417-423. ISI | PUBMED
30. Donahue RP, Abbott RD, Bloom E, Reed DM, Yano K. Central obesity and coronary heart disease in men. Lancet. 1987;1:821-824. ISI | PUBMED
31. Ducimetiere P, Richard J, Cambien F. The pattern of subcutaneous fat distribution in middle-aged men and the risk of coronary heart disease: the Paris Prospective Study. Int J Obes. 1986;10:229-240. ISI | PUBMED
32. Svendsen O, Hassager C, Christiansen C. Effect of an energy-restrictive diet, with or without exercise, on lean tissue mass, resting metabolic rate, cardiovascular risk factors, and bone in overweight postmenopausal women. Am J Med. 1993;95:131-140. FULL TEXT | ISI | PUBMED
33. Wing R, Jeffrey R. Effect of modest weight loss on changes in cardiovascular risk factors. Int J Obes Relat Metab Disord. 1995;19:67-73. ISI | PUBMED
34. Wing R, Matthews K, Kuller L, Meilahn E, Plantinga P. Waist to hip ratio in middle aged women. Arterioscler Thromb. 1991;11:1250-1257. FREE FULL TEXT


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTER

Abdominal Adiposity and Risk of Heart Disease
Jacob C. Seidell, Claude Bouchard, Kathryn M. Rexrode, Vincent J. Carey, Charles H. Hennekens, Ellen Walters, Graham A. Colditz, Meir J. Stampfer, Walter C. Willett, and JoAnn E. Manson
JAMA. 1999;281(24):2284-2285.
EXTRACT | FULL TEXT  

RELATED ARTICLE

December 2, 1998
JAMA. 1998;280(21):1885-1886.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Adiposity indicators and dementia over 32 years in Sweden
Gustafson et al.
Neurology 2009;73:1559-1566.
ABSTRACT | FULL TEXT  

Does abdominal obesity have a similar impact on cardiovascular disease and diabetes? A study of 91 246 ambulant patients in 27 European Countries
Fox et al.
Eur Heart J 2009;0:ehp371v1-ehp371.
ABSTRACT | FULL TEXT  

Hypocaloric high-protein diet improves fatty liver and hypertriglyceridemia in sucrose-fed obese rats via two pathways
Uebanso et al.
Am. J. Physiol. Endocrinol. Metab. 2009;297:E76-E84.
ABSTRACT | FULL TEXT  

Conjugated Linoleic Acids Reduce Body Fat in Healthy Postmenopausal Women
Raff et al.
J. Nutr. 2009;139:1347-1352.
ABSTRACT | FULL TEXT  

Visceral adiposity and arterial stiffness: echocardiographic epicardial fat thickness reflects, better than waist circumference, carotid arterial stiffness in a large population of hypertensives
Natale et al.
Eur J Echocardiogr 2009;10:549-555.
ABSTRACT | FULL TEXT  

Getting the message across: mechanisms of physiological cross talk by adipose tissue
Lee et al.
Am. J. Physiol. Endocrinol. Metab. 2009;296:E1210-E1229.
ABSTRACT | FULL TEXT  

Adiposity and Incidence of Heart Failure Hospitalization and Mortality: A Population-Based Prospective Study
Levitan et al.
Circ Heart Fail 2009;2:202-208.
ABSTRACT | FULL TEXT  

Depressive Symptoms and Increased Visceral Fat in Middle-Aged Women
Everson-Rose et al.
Psychosom. Med. 2009;71:410-416.
ABSTRACT | FULL TEXT  

Association of Hip Circumference With Incident Diabetes and Coronary Heart Disease: The Atherosclerosis Risk in Communities Study
Parker et al.
Am J Epidemiol 2009;169:837-847.
ABSTRACT | FULL TEXT  

General and Abdominal Adiposity and Risk of Stroke in Chinese Women
Zhang et al.
Stroke 2009;40:1098-1104.
ABSTRACT | FULL TEXT  

Proposed Criteria for Metabolic Syndrome in Japanese Based on Prospective Evidence: The Hisayama Study
Doi et al.
Stroke 2009;40:1187-1194.
ABSTRACT | FULL TEXT  

Ambient Air Pollution Exaggerates Adipose Inflammation and Insulin Resistance in a Mouse Model of Diet-Induced Obesity
Sun et al.
Circulation 2009;119:538-546.
ABSTRACT | FULL TEXT  

Anthropometry, CT, and DXA as predictors of GH deficiency in premenopausal women: ROC curve analysis
Bredella et al.
J. Appl. Physiol. 2009;106:418-422.
ABSTRACT | FULL TEXT  

Metabolic Syndrome Pathophysiology and Clinical Presentation
Handelsman
Toxicol Pathol 2009;37:18-20.
ABSTRACT | FULL TEXT  

Impact of body composition on very-low-density lipoprotein-triglycerides kinetics
Gormsen et al.
Am. J. Physiol. Endocrinol. Metab. 2009;296:E165-E173.
ABSTRACT | FULL TEXT  

CHAPTER 12 Prevention of Cardiovascular Disease
Rosengren et al.
ESC Textbook of Cardiovascular Medicine 2009;2:med-9780199566990-chapter-med-9780199566990-chapter.
ABSTRACT | FULL TEXT  

Adipose tissue dysfunction in obesity, diabetes, and vascular diseases
Hajer et al.
Eur Heart J 2008;29:2959-2971.
ABSTRACT | FULL TEXT  

HIV and the menopause
Fan et al.
Menopause Int 2008;14:163-168.
ABSTRACT | FULL TEXT  

Decreased lipin 1{beta} expression in visceral adipose tissue is associated with insulin resistance in polycystic ovary syndrome
Mlinar et al.
Eur J Endocrinol 2008;159:833-839.
ABSTRACT | FULL TEXT  

Depressive Symptoms and Change in Abdominal Obesity in Older Persons
Vogelzangs et al.
Arch Gen Psychiatry 2008;65:1386-1393.
ABSTRACT | FULL TEXT  

Chronic Particulate Exposure, Mortality, and Coronary Heart Disease in the Nurses' Health Study
Puett et al.
Am J Epidemiol 2008;168:1161-1168.
ABSTRACT | FULL TEXT  

The combined relations of adiposity and smoking on mortality
Koster et al.
Am. J. Clin. Nutr. 2008;88:1206-1212.
ABSTRACT | FULL TEXT  

Obesity and the Metabolic Syndrome in Developing Countries
Misra and Khurana
J. Clin. Endocrinol. Metab. 2008;93:s9-s30.
ABSTRACT | FULL TEXT  

Nutrition Protocols for the Prevention of Cardiovascular Disease
Retelny et al.
Nutr Clin Pract 2008;23:468-476.
ABSTRACT | FULL TEXT  

Measures of Obesity and Cardiovascular Risk Among Men and Women
Gelber et al.
J Am Coll Cardiol 2008;52:605-615.
ABSTRACT | FULL TEXT  

Which Measures of Obesity Best Predict Cardiovascular Risk?
Litwin
J Am Coll Cardiol 2008;52:616-619.
FULL TEXT  

Waist Circumference Measurement in Clinical Practice
Ness-Abramof and Apovian
Nutr Clin Pract 2008;23:397-404.
ABSTRACT | FULL TEXT  

Does adding metformin to clomifene citrate lead to higher pregnancy rates in a subset of women with polycystic ovary syndrome?
Moll et al.
Hum Reprod 2008;23:1830-1834.
ABSTRACT | FULL TEXT  

A Practical 'ABCDE' Approach to the Metabolic Syndrome
Blaha et al.
Mayo Clin Proc. 2008;83:932-943.
ABSTRACT | FULL TEXT  

Population-Based Prevention of Obesity: The Need for Comprehensive Promotion of Healthful Eating, Physical Activity, and Energy Balance: A Scientific Statement From American Heart Association Council on Epidemiology and Prevention, Interdisciplinary Committee for Prevention (Formerly the Expert Panel on Population and Prevention Science)
Kumanyika et al.
Circulation 2008;118:428-464.
ABSTRACT | FULL TEXT  

Waist Circumference and Mortality
Koster et al.
Am J Epidemiol 2008;167:1465-1475.
ABSTRACT | FULL TEXT  

Lifestyle and Risk of Cardiovascular Disease and Type 2 Diabetes in Women: A Review of the Epidemiologic Evidence
Bassuk and Manson
AMERICAN JOURNAL OF LIFESTYLE MEDICINE 2008;2:191-213.
ABSTRACT  

Abdominal Obesity and the Metabolic Syndrome: Contribution to Global Cardiometabolic Risk
Despres et al.
Arterioscler. Thromb. Vasc. Bio. 2008;28:1039-1049.
ABSTRACT | FULL TEXT  

Alcohol drinking frequency in relation to subsequent changes in waist circumference
Tolstrup et al.
Am. J. Clin. Nutr. 2008;87:957-963.
ABSTRACT | FULL TEXT  

Primary prevention of coronary heart disease in women
Rees et al.
Menopause Int 2008;14:40-45.
ABSTRACT | FULL TEXT  

Body Fat Distribution and Risk of Coronary Heart Disease in Men and Women in the European Prospective Investigation Into Cancer and Nutrition in Norfolk Cohort: A Population-Based Prospective Study
Canoy et al.
Circulation 2007;116:2933-2943.
ABSTRACT | FULL TEXT  

Does Waist Circumference Predict Diabetes and Cardiovascular Disease Beyond Commonly Evaluated Cardiometabolic Risk Factors?
Janiszewski et al.
Diabetes Care 2007;30:3105-3109.
ABSTRACT | FULL TEXT  

International Day for the Evaluation of Abdominal Obesity (IDEA): A Study of Waist Circumference, Cardiovascular Disease, and Diabetes Mellitus in 168 000 Primary Care Patients in 63 Countries
Balkau et al.
Circulation 2007;116:1942-1951.
ABSTRACT | FULL TEXT  

Combined Effect of Low-Risk Dietary and Lifestyle Behaviors in Primary Prevention of Myocardial Infarction in Women
Akesson et al.
Arch Intern Med 2007;167:2122-2127.
ABSTRACT | FULL TEXT  

Adiposity and cardiovascular disease: are we using the right definition of obesity?
Poirier
Eur Heart J 2007;28:2047-2048.
FULL TEXT  

Visceral Adipose Tissue, a Potential Risk Factor for Carotid Atherosclerosis: Results of the Multicultural Community Health Assessment Trial (M-CHAT)
Lear et al.
Stroke 2007;38:2422-2429.
ABSTRACT | FULL TEXT  

Consequences of Change in Waist Circumference on Cardiometabolic Risk Factors Over 9 Years: Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR)
Balkau et al.
Diabetes Care 2007;30:1901-1903.
FULL TEXT  

Abdominal Adiposity and Mortality in Chinese Women
Zhang et al.
Arch Intern Med 2007;167:886-892.
ABSTRACT | FULL TEXT  

Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies
de Koning et al.
Eur Heart J 2007;0:ehm026v1-7.
ABSTRACT | FULL TEXT  

The Effect of Menopause on the Metabolic Syndrome Among Korean Women: The Korean National Health and Nutrition Examination Survey, 2001
Kim et al.
Diabetes Care 2007;30:701-706.
ABSTRACT | FULL TEXT  

Estimating whole body intermuscular adipose tissue from single cross-sectional magnetic resonance images
Ruan et al.
J. Appl. Physiol. 2007;102:748-754.
ABSTRACT | FULL TEXT  

Sagittal abdominal diameter: no advantage compared with other anthropometric measures as a correlate of components of the metabolic syndrome in elderly from the Hoorn Study.
Mukuddem-Petersen et al.
Am. J. Clin. Nutr. 2006;84:995-1002.
ABSTRACT | FULL TEXT  

Applying Mixed Regression Models to the Analysis of Repeated-Measures Data in Psychosomatic Medicine
Blackwell et al.
Psychosom. Med. 2006;68:870-878.
ABSTRACT | FULL TEXT  

Intake of macronutrients as predictors of 5-y changes in waist circumference.
Halkjaer et al.
Am. J. Clin. Nutr. 2006;84:789-797.
ABSTRACT | FULL TEXT  

Complex Actions of Sex Steroids in Adipose Tissue, the Cardiovascular System, and Brain: Insights from Basic Science and Clinical Studies
Turgeon et al.
Endocr. Rev. 2006;27:575-605.
ABSTRACT | FULL TEXT  

Weight, shape, and mortality risk in older persons: elevated waist-hip ratio, not high body mass index, is associated with a greater risk of death.
Price et al.
Am. J. Clin. Nutr. 2006;84:449-460.
ABSTRACT | FULL TEXT  

Body Mass Index, Metabolic Syndrome, and Risk of Type 2 Diabetes or Cardiovascular Disease
Meigs et al.
J. Clin. Endocrinol. Metab. 2006;91:2906-2912.
ABSTRACT | FULL TEXT  

Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects.
Graham et al.
NEJM 2006;354:2552-2563.
ABSTRACT | FULL TEXT  

Obesity and cardiovascular events in patients with established coronary disease
Domanski et al.
Eur Heart J 2006;27:1416-1422.
ABSTRACT | FULL TEXT  

The Enlarging Body of Evidence: Obesity and Chronic Kidney Disease
Chertow et al.
J. Am. Soc. Nephrol. 2006;17:1501-1502.
FULL TEXT  

Abdominal obesity: the most prevalent cause of the metabolic syndrome and related cardiometabolic risk
Despres
Eur Heart J Suppl 2006;8:B4-B12.
ABSTRACT | FULL TEXT  

Adipose tissue as an endocrine organ: implications of its distribution on free fatty acid metabolism
Jensen
Eur Heart J Suppl 2006;8:B13-B19.
ABSTRACT | FULL TEXT  

Abdominal obesity, insulin resistance, and cardiovascular risk in pre-diabetes and type 2 diabetes
Haffner
Eur Heart J Suppl 2006;8:B20-B25.
ABSTRACT | FULL TEXT  

Cardiovascular diseases in women: a statement from the policy conference of the European Society of Cardiology
Stramba-Badiale et al.
Eur Heart J 2006;27:994-1005.
ABSTRACT | FULL TEXT  

Body Composition and Adiponectin Serum Concentrations in Adult Patients with Cystic Fibrosis
Moriconi et al.
J. Clin. Endocrinol. Metab. 2006;91:1586-1590.
ABSTRACT | FULL TEXT  

Metabolic syndrome and the progression of carotid intima-media thickness in elderly women.
Hassinen et al.
Arch Intern Med 2006;166:444-449.
ABSTRACT | FULL TEXT  

Insights From the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: Gender Differences in Traditional and Novel Risk Factors, Symptom Evaluation, and Gender-Optimized Diagnostic Strategies
Shaw et al.
J Am Coll Cardiol 2006;47:S4-S20.
ABSTRACT | FULL TEXT  

What aspects of body fat are particularly hazardous and how do we measure them?
Snijder et al.
Int J Epidemiol 2006;35:83-92.
FULL TEXT  

The epidemiology of overweight and obesity: public health crisis or moral panic?
Campos et al.
Int J Epidemiol 2006;35:55-60.
FULL TEXT  

Visceral adipose tissue-derived serine protease inhibitor: A unique insulin-sensitizing adipocytokine in obesity
Hida et al.
Proc. Natl. Acad. Sci. USA 2005;102:10610-10615.
ABSTRACT | FULL TEXT  

Hostility Scores Are Associated With Increased Risk of Cardiovascular Events in Women Undergoing Coronary Angiography: A Report from the NHLBI-Sponsored WISE Study
Olson et al.
Psychosom. Med. 2005;67:546-552.
ABSTRACT | FULL TEXT  

Insulin-sensitizing agents: use in pregnancy and as therapy in polycystic ovary syndrome
Checa et al.
Hum Reprod Update 2005;11:375-390.
ABSTRACT | FULL TEXT  

Combined Influence of Body Mass Index and Waist Circumference on Coronary Artery Disease Risk Factors Among Children and Adolescents
Janssen et al.
Pediatrics 2005;115:1623-1630.
ABSTRACT | FULL TEXT  

Enlarged Waist Combined With Elevated Triglycerides Is a Strong Predictor of Accelerated Atherogenesis and Related Cardiovascular Mortality in Postmenopausal Women
Tanko et al.
Circulation 2005;111:1883-1890.
ABSTRACT | FULL TEXT  

Adipose tissue in muscle: a novel depot similar in size to visceral adipose tissue
Gallagher et al.
Am. J. Clin. Nutr. 2005;81:903-910.
ABSTRACT | FULL TEXT  

Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men
Wang et al.
Am. J. Clin. Nutr. 2005;81:555-563.
ABSTRACT | FULL TEXT  

Differential Responses of Visceral and Subcutaneous Fat Depots to Nutrients
Einstein et al.
Diabetes 2005;54:672-678.
ABSTRACT | FULL TEXT  

Truncal Adiposity, Relative Growth Hormone Deficiency, and Cardiovascular Risk
Miller et al.
J. Clin. Endocrinol. Metab. 2005;90:768-774.
ABSTRACT | FULL TEXT  

Cumulative Lead Exposure and Prospective Change in Cognition among Elderly Men: The VA Normative Aging Study
Weisskopf et al.
Am J Epidemiol 2004;160:1184-1193.
ABSTRACT | FULL TEXT  

Joint effects of physical activity, body mass index, waist circumference and waist-to-hip ratio with the risk of cardiovascular disease among middle-aged Finnish men and women
Hu et al.
Eur Heart J 2004;25:2212-2219.
ABSTRACT | FULL TEXT  

Obesity and the Risk of New-Onset Atrial Fibrillation
Wang et al.
JAMA 2004;292:2471-2477.
ABSTRACT | FULL TEXT  

Sagittal Abdominal Diameter and Risk of Sudden Death in Asymptomatic Middle-Aged Men: The Paris Prospective Study I
Empana et al.
Circulation 2004;110:2781-2785.
ABSTRACT | FULL TEXT  

The National Cholesterol Education Program Diet vs a Diet Lower in Carbohydrates and Higher in Protein and Monounsaturated Fat: A Randomized Trial
Aude et al.
Arch Intern Med 2004;164:2141-2146.
ABSTRACT | FULL TEXT  

Association of Visceral Adipose Tissue with Incident Myocardial Infarction in Older Men and Women: The Health, Aging and Body Composition Study
Nicklas et al.
Am J Epidemiol 2004;160:741-749.
ABSTRACT | FULL TEXT  

Pounds Off With Empowerment (POWER): A Clinical Trial of Weight Management Strategies for Black and White Adults With Diabetes Who Live in Medically Underserved Rural Communities
Mayer-Davis et al.
AJPH 2004;94:1736-1742.
ABSTRACT | FULL TEXT  

A Nurse-Coaching Intervention for Women With Type 2 Diabetes
Whittemore et al.
The Diabetes Educator 2004;30:795-804.
 

Metabolic Syndrome in Normal-Weight Americans: New definition of the metabolically obese, normal-weight individual
St-Onge et al.
Diabetes Care 2004;27:2222-2228.
ABSTRACT | FULL TEXT  

Sex differences in body fat distribution and carotid intima media thickness: cross sectional survey using data from the British regional heart study
Lawlor et al.
J. Epidemiol. Community Health 2004;58:700-704.
ABSTRACT | FULL TEXT  

Growth Hormone-Releasing Hormone in HIV-Infected Men With Lipodystrophy: A Randomized Controlled Trial
Koutkia et al.
JAMA 2004;292:210-218.
ABSTRACT | FULL TEXT  

Hormones and Supplements: Do They Work?: Use of Growth Hormone for Prevention or Treatment of Effects of Aging
Harman and Blackman
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2004;59:B652-B658.
ABSTRACT | FULL TEXT  

Very Low-Fat (12%) and High Monounsaturated Fat (35%) Diets Do Not Differentially Affect Abdominal Fat Loss in Overweight, Nondiabetic Women
Clifton et al.
J. Nutr. 2004;134:1741-1745.
ABSTRACT | FULL TEXT  

Regional Body Composition Changes Exhibit Opposing Effects on Coronary Heart Disease Risk Factors
Okura et al.
Arterioscler. Thromb. Vasc. Bio. 2004;24:923-929.
ABSTRACT | FULL TEXT  

Obesity and the Risk of Parkinson's Disease
Chen et al.
Am J Epidemiol 2004;159:547-555.
ABSTRACT | FULL TEXT  

Waist circumference and not body mass index explains obesity-related health risk
Janssen et al.
Am. J. Clin. Nutr. 2004;79:379-384.
ABSTRACT | FULL TEXT  

Association of Total and Central Obesity with Mortality in Postmenopausal Women with Coronary Heart Disease
Kanaya et al.
Am J Epidemiol 2003;158:1161-1170.
ABSTRACT | FULL TEXT  

Screening and Interventions for Obesity in Adults: Summary of the Evidence for the U.S. Preventive Services Task Force
McTigue et al.
ANN INTERN MED 2003;139:933-949.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.